Less than 1 min.Read

Atomo Diagnostics: Launching COVID-19 test in India

September 23, 2020

Atomo Diagnostics (AT1) has entered an agreement with PinkTech Design Private (DIVOC) to launch its COVID-19 antibody test in India
This agreement will see DIVOC distribute the AtomoRapid COVID-19 on a non-exclusive basis to government and corporate entities as well as India’s home-visit network
Once DIVOC has obtained product registration approval for professional use, which estimated for Q2 FY21, the Atomo will provide 77,000 antibody test kits
Atomo will receive a fixed transfer price per unit as well as a percentage of revenue received on final product sales
The AtomoRapid COVID-19 test is a single-use, handled, TGA approved device that gives an accurate result in as little as 15 minutes
Atomo is up 7.14 per cent on the market and shares are trading for 37.5 cents each